Oncology News

• Single Negative Colonoscopy Predicts Low Colorectal Cancer Risk A single negative colonoscopy is associated with long-lasting, significant reductions in colorectal cancer risk, but only if the colonoscopy is of high quality.
  Medscape Medical News, May 26, 2020
• Healthcare Workers May Be at Risk Early in COVID-19 Outbreak In the early stages of a COVID-19 outbreak, healthcare workers may not recognize that patients have the disease, which can put them at risk, new data suggest.
  Medscape Medical News, May 22, 2020
• Primary Cardiac Tumors: A Clarion Call for Cardio-Oncology New data confirm the rarity and lethality of these tumors, yet patients are often diagnosed after surgery and only then referred to an oncologist.
  Medscape Medical News, May 22, 2020
• Onc Daily: COVID-19 Impedes Cancer Trials, Bladder Cancer Study Here are the most important stories that Medscape Oncology's editors picked for you to read today.
  Medscape Medical News, May 22, 2020
• More Than 200 International Cancer Trials Suspended Due to COVID-19 Globally, more than 200 clinical trials have been suspended as a result of factors related to the COVID-19 pandemic.
  Medscape Medical News, May 22, 2020
• 'Every Patient Would Applaud' Bladder Cancer Surveillance Study High-risk bladder cancer post-surgery follow-up is intensive and based on expert opinion. A new study questions that intensity and opinion.
  Medscape Medical News, May 21, 2020
• Onc Daily: Oncologists' Income Up, Prostate Cancer on the Rise These are the most important oncology stories you need to know about today.
  Medscape Medical News, May 21, 2020
• J&J Baby Powder Withdrawn in US After Years of Cancer Litigation After years of litigation over talc's potentially causing cancer, Johnson & Johnson has decided to withdraw its baby powder product in the United States and Canada.
  Medscape Medical News, May 21, 2020
• Oncologists' Income and Satisfaction Are Up Nearly all the oncologists who contributed to a new Medscape report say they would choose their specialty again, and earnings are up from the previous year.
  Medscape Medical News, May 21, 2020
• Alert FDA Approves Olaparib for Certain Metastatic Prostate Cancers Another PARP inhibitor, Lynparza, has been approved for use in prostate cancer.
  FDA Approvals, May 20, 2020
• EAU 2020Sexual Distress, Depression After Prostate Cancer Treatment A lack of discussion about sexual dysfunction makes it a difficult problem to solve, but a new survey shines light on the scope of the problem after prostate cancer.
  Medscape Medical News, May 20, 2020
• Onc Daily: World-First Saliva Test, ID'ing 'Exceptional Responders' These are the most important oncology stories you need to know about today.
  Medscape Medical News, May 20, 2020
• Advanced Prostate Cancers Still Rising in US The first study to report prostate cancer incidence up to and including 2016 shows that regional and metastatic disease continue to rise.
  Medscape Medical News, May 20, 2020
• Tumor Molecular Profiling May Help Identify 'Exceptional Responders' An NCI pilot study to identify the genetic and molecular changes that underlie exceptional responses has proven that the approach is feasible.
  Medscape Medical News, May 20, 2020
• ACC 2020Universal CAR-T Therapy Produces CRs in Relapsed/Refractory T-ALL A universal chimeric antigen receptor (CAR) T-cell therapy produced responses in adults with relapsed or refractory T-cell acute lymphoblastic leukemia (T-ALL) in initial findings from an ongoing study.
  Medscape Medical News, May 20, 2020
• ACC 2020Radiation-Associated Childhood Cancer in Congenital Heart Disease Among children with congenital heart disease, exposure to low-dose ionizing radiation from cardiac procedures increased cancer risk three times that of similar patients without such exposures.
  Medscape Medical News, May 20, 2020
• COVID-19 and Physician Income: Some Suffer While Others Do Not Like COVID-19's symptoms, the pandemic's effect on physician income has been worse for some specialties than for others. Here's a rundown of how various doctors are dealing financially.
  Medscape Medical News, May 20, 2020
• Onc Daily: New Drug for GIST, PARPi for Prostate Cancer These are the most important oncology stories you need to know about today.
  Medscape Medical News, May 19, 2020
• World First: Saliva Test Detects Occult HPV Oral Cancer A saliva test still under development has scored a world first: it led to a finding of oral cancer after detecting rising human papillomavirus DNA levels in subsequent oral rinses.
  Medscape Medical News, May 19, 2020
• Alert First PARP Inhibitor Approved for Metastatic Prostate Cancer The FDA has granted rucaparib (Rubraca) an accelerated approval for use in BRCA1/BRCA2 mutation-positive metastatic castration-resistant prostate cancer.
  FDA Approvals, May 19, 2020